Does tenofovir-containing first-line antiretroviral therapy mitigate the impact of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance? (Clinical Infectious Diseases, 2018)

(untitled) - Inzaule, SC; Rinke de Wit, TF; Hamers, RL; Pan-African Studies to Evaluate Resistance